Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-
%
0,00%
Latest
High
Low
Volume
0
Turnover (NOK)
0
Market Value (MNOK)
35,1
Time (Latest trade)

Board

CEO

  • Ronny Hermansen

Chairperson of the Board

  • Jethro Holter

Board

  • Camilla Huse Bondesson
  • Marie Buchmann
  • Richard Kurtz
  • Rune Sørum
  • Thorvald Steen

Largest Owners

Name Capital % Votes % Date
Bio-Rad Luxembourg S.À.R.L. 22,55 22,55 2024-03-27
Avanza Bank AB 15,75 15,75 2024-03-27
Muen Invest AS 6,63 6,63 2024-07-01
S. Munkhaugen AS 4,15 4,15 2024-03-27
Nordnet Bank AB 4,15 4,15 2024-03-27
Lucellum AS 3,91 3,91 2024-03-27
Biohit Oyj 3,38 3,38 2024-03-27
Ochrino AS 2,98 2,98 2024-03-27
Leif Jørgen Moger 2,81 2,81 2024-03-27
Stella Invest AS 2,51 2,51 2024-03-27

Insider trading

*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2024-11-15 Delårsrapport 2024-Q3

  • 2025-02-26 Bokslutskommuniké 2024